| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Institut Curie [Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from fundamental research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Care The Institut Curie Hospital Group is a reference center for breast cancer, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians and doctors are mobilizing … Sectors: | 897 | 733 | 139 |
 | SATT Paris-Saclay [Automatic translation follows] Innovation with confidence Created in 2014 and resulting from the "Investments for the Future" Program, SATT Paris-Saclay is the Technology Transfer Acceleration Company of the Paris-Saclay Cluster. A common player for both entities - Université Paris-Saclay and Institut Polytechnique de Paris - SATT has an investment capacity of 66 million euros over 10 years to finance and support the development of research work from the region and technology transfer to the markets. Innovation, Technology Transfer, and Start-up Tags: SATT Network Sectors: | 227 | 108 | 147 |
 | LUTECH Au service des talents créatifs et technologiques de l'Alliance Sorbonne Université pour innover le monde de demain LUTECH is a private technology transfer company with exclusive rights to source, protect, develop and commercialize scientific findings stemming from the research laboratories of its partners and shareholders. Lutech aims at facilitating the tranfer of early stage innovations with a real potential to improve life quality, tranform industries, and create tremendous social & economic value, from the lab to successful products and services, by investing in the development of convincing proof of concept and prototypes. Lutech is partnering with operating companies and investors, … Tags: SATT Network | 47 | 11 | 25 |
 | PULSALYS [Automatic translation follows] Incubates Deep Tech startups & accelerates scientific innovations from the R&D labs of Lyon-St Etienne 🚀 PULSALYS, the Deep Tech innovation incubator and accelerator of Lyon & St Etienne, builds the innovative products & services of tomorrow, by transforming scientific discoveries from the laboratories of the University of Lyon into economic opportunities for companies and startups. Created in December 2013 as part of the Future Investment Program (PIA) under the status of Technology Transfer Acceleration Company (SATT), PULSALYS has become a key player in the attractiveness and economic development of the Lyon - St-Etienne region. Chemistry & … Tags: SATT Network Sectors: | 416 | 119 | 342 |
 | SATT Sud-Est Transforming an invention into an innovation is a wonderful experience. And we’re fortunate, it is our job. From dream to reality, from lab to market | a researcher and his/her team make an extraordinary discovery. But how can an idea be transformed into a solution, and how can an invention be turned into an innovation? This is the start of a race against time to find the partner company capable of upholding that ambition. Fortunately, SATT Sud-Est is there to help in this undertaking and make this great story come true. Transforming an invention into an innovation is a wonderful … Tags: SATT Network Sectors: | 273 | 79 | 101 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3469 | 2587 | 832 |
 | Pierre Fabre Laboratories New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale … Sectors: | 742 | 550 | 146 |
 | Apec - Association Pour l'Emploi des Cadres [Automatic translation follows] As a player in the executive employment market, Apec supports and advises executives throughout their careers to anticipate and prepare for their development, as well as young people from higher education to prepare for their first job search. It offers companies services to optimize their recruitment and internal skills management. As an observatory of the executive employment market, Apec provides analysis and benchmarks on major trends. Apec supports and advises executives throughout their careers Executives, whether they are monitoring or reflecting, in a process of development or mobility, internal or external, find at Apec all the information … Sectors: | 1885 | 1428 | 458 |
 | Région Nouvelle-Aquitaine [Automatic translation follows] Official page of the Nouvelle-Aquitaine Region. The Regional Council, together with the Regional Economic, Social and Environmental Council, makes up the Nouvelle-Aquitaine Region. Its regional assembly has 183 regional councillors, a standing committee and sectoral committees. Business, Vocational training, Youth, Transport, Ecological transition, Europe, and Regional planning Sectors: | 3345 | 2679 | 643 |
 | Région Ile de France The Paris Region is a major business and techno hub in Europe. Standing at the crossroads of European and worldwide trade, the Paris Region is France's leading economic region. It represents 31% of French GDP. Consisting of 8 départements and 1,280 municipalities, the Paris Region hosts the largest population of french Regions : 12.5 million inhabitants, that is younger than the national average. As Europe’s leading employment area, it boasts a highly qualified workforce : 33% of French executives. The Paris Region hosts 22% of France’s universities, 25% of its engineering schooland 20% of its business schools. Invest in Paris … Sectors: | 4852 | 3992 | 690 |
 | Business France Business France is the national agency for the internationalization of the French economy. It is responsible for the international development of companies and their exports, as well as prospecting for and welcoming international investments in France. It promotes the attractiveness and business image of France, its companies and its territories. It manages and develops the V.I.E (Volontariat International en Entreprise). Created on January 1, 2015, Business France is a merger of UBIFRANCE and the AFII (French Agency for International Investments). Business France has 1,500 employees located in France and in 70 countries. It relies on a network of public and … Sectors: | 5131 | 3148 | 2272 |
 | BioValley France Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment … Sectors: | 401 | 155 | 308 |
 | Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: | 624 | 377 | 382 |
 | Clubster NSL [Automatic translation follows] 360 members | #innovation #health #nutrition #longevity | contact@clubster-nsl.com Clubster Santé, a network of health companies in the Nord-Pas de Calais region, aims to develop, promote, represent and lead the regional health sector. Our network has major unifying missions: to be the spokesperson for the regional health sector, to facilitate exchanges and partnerships between companies and to support a dynamic and wealth-creating sector via a specialized investment platform. Personalized medicine, Inter-company training, HIPÂ, Concept Room, Invest'Innove, Investment platform, Information, Mutualization, Innovation, Networking, Business Angels Academy, nutrition, longevity, and eurasanté Sectors: | 287 | 97 | 213 |
 | Greater Paris University Hospitals - AP-HP Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par … Sectors: | 2139 | 1465 | 149 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 828 | 483 | 507 |
 | Eurasanté Accélérateur des innovations santé-nutrition, bien vieillir en région Hauts-de-France Eurasanté is a regional economic development agency specialized in the the health sector. It supports the different actors dedicated to health related activities with their research, creation and development projects. The Biology, Nutrition and Health Sector of the Nord-Pas-De-Calais represents 800 companies, and 22 000 employees. Located at the heart of a business park of over 300 hectares gathering 7 hospitals, 50 research laboratories, 145 companies, 4 universities, 5 specialized training institutes, it constitutes a unique business environment in the largest university-hospital campus over Europe. 3 kinds of services are part … Sectors: | 490 | 281 | 260 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: | 1561 | 1421 | 60 |
 | BFM Business [Automatic translation follows] France's leading economic and financial news channel. BFM Business TV is France's leading economic and financial news channel. It stands out for its programming focused on the search for expertise. Programs focusing on economic news have established themselves as economic news events. "Good Morning Business" for example, offers guests, the latest innovations, editorials and information on underlying trends on its set. BFM Business TV is also available live on our website as well as on a dedicated application. Tech, Stock Market, Economy, Real Estate, Business, Automobile, and High-Tech Sectors: | 7787 | 7006 | 872 |
 | Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: | 598 | 332 | 75 |
 | Pfizer We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: | 1358 | 1054 | 137 |
 | CEA The CEA is the French Alternative Energies and Atomic Energy Commission ("Commissariat à l'énergie atomique et aux énergies alternatives"). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and … Sectors: | 2653 | 1686 | 331 |
 | Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: | 12215 | 9271 | 1569 |
 | AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: | 3776 | 2611 | 203 |
 | Linkera [Automatic translation follows] Support for fundraising and sale/acquisition - Valuation of startups and VSEs/SMEs - UGAP Rating Linkera is the essential solution dedicated to optimizing business acquisition and sale transactions. The platform connects business owners and potential buyers. Each month, it presents companies and assets worth millions of euros to nearly 2,000 users. Innovation, Entrepreneurship, Rating, Financial & extra-financial advice, investment, algorithm, data, UGAP, Valuation, Fundraising, Sale, Acquisitions, Financing, Startups, VSEs, and SMEs Sectors: | 1112 | 102 | 1055 |
 | Le Figaro [Automatic translation follows] Le Figaro, the culture of freedom since 1826, the leading general daily newspaper and the most visited news site in France. With an audience of over 9 million unique visitors (source: Médiamétrie/NetRatings), the site is characterized by the quality and depth of its content, the result of the complementarity between its paper editorial teams (daily and magazines) and its web editorial team; by its Internet 2.0 uses and the importance of video, which has become a central element of the content offering. Lefigaro.fr also bases its development on the synergies built with the other sites of the … Sectors: | 3868 | 3524 | 239 |
 | CNRS Innovation Filiale du CNRS & de BPI France. 30 ans d'expertise au service de l'innovation et du transfert de technologies. CNRS Innovation, established in 1992, is a French public limited company, now a subsidiary of the CNRS at 90% and 10% Bpifrance Financement. Its mission is to transfer innovative technologies, mainly originating from the CNRS, to the industry. Its action extends from the receipt of projects to the granting of exploitation rights through consulting in Intellectual Property strategies, participation in the filing of patent applications, seeking of industrial partners, negotiating and drafting of exploitation agreements, and management of patent portfolios. CNRS … Sectors: | 503 | 160 | 348 |
 | Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: | 4519 | 2883 | 644 |
 | Europe 1 [Automatic translation follows] Europe 1, the radio that informs and entertains you every day Europe 1 is a private generalist radio station belonging to the Lagardère group. Created in 1955, it offers both information and entertainment, it is the radio of the event. Find us also on www.europe1.fr, faceboook, twitter and Instagram. https://www.europe1.fr/emissions/la-france-bouge Radio, Journalism, Information, Entertainment, Programs, and News | 1049 | 900 | 108 |
 | Université Paris-Saclay [Automatic translation follows] 14 varied and complementary establishments are the Paris-Saclay University: 3 universities *, 4 grandes écoles ** and 7 research organizations ***. In total, we represent 48,000 students, 9,000 researchers and teacher-researchers, 4,600 doctoral students and 275 laboratories. 14 Various goal complementary institutions Make up University Paris-Saclay: 3 universities *, 4 Prestigious University-Level Colleges ** and 7 Research Organizations ***. WE represent 9,000 profits and researchers, 4,600 PhD Students, 275 Laboratories and 48,000 students. * University Paris-Sud, University Versailles St-Quentin-en-Yvelines and University of Evry. ** Graduate School Optical Institute, Agroparistech, CentralsUpelec, Normal School Paris-Saclay. *** CEA, CNRS, IHES, … Sectors: | 1072 | 592 | 75 |
Health